ABX464: Clinical Trials

5 trials of ABX464, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 21Completed 1

Follow ABX464: new trials by email Literature Review of ABX464 trials Research Report on ABX464

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Pharmacokinetics Study in Healthy Japanese Volunteers
ABX464, Placebo - Healthy Volunteers
Phase 1CompletedAbivax S.A.482021-09-272023-01-26
Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464
Caffeine, ABX464, Fluvoxamine - Healthy
Phase 1CompletedAbivax S.A.592020-12-172026-11-09
A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults
ABX464 150mg, ABX464 50mg - HIV Infections, Health Volunteers
Phase 1 / Phase 2CompletedAbivax S.A.362017-03-272023-03-31
Food Effect on Pharmacokinetic Parameters of ABX464
ABX464 Single dose, ABX464 Repeated dose - Healthy Volunteers
Phase 1CompletedAbivax S.A.482014-09-012016-04-08
ABX464 First in Man Study
ABX464 - Healthy Volunteers
Phase 1CompletedAbivax S.A.242014-03-012024-05-17

Conditions studied

HIV Infections (1)

Sponsors

Abivax S.A. (5)

Countries

France (1)  ·  Japan (1)  ·  Mauritius (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Paul Gineste (1)

Results publications

PMID 27799203, PMID 27999038, PMID 34436569